GO:0003242 cardiac chamber ballooning: Morphogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003242 cardiac chamber ballooning is the morphogenic growth process in which the chambers of the heart expand in size, contributing to their shaping.
• Chamber ballooning is a key step in cardiac morphogenesis that transforms the linear heart tube into a multi-chambered organ.
• Myosin Vb (MYO5B) is required for correct trafficking of N-cadherin and for cardiac chamber ballooning, linking vesicle transport to chamber expansion.
• The process is evolutionarily conserved and is central to the origin of cardiac chambers across vertebrates.
• Extracellular matrix remodeling, including Hapln1a-dependent ECM expansion, promotes heart morphogenesis and chamber shaping.
• Disruption of chamber ballooning is associated with congenital heart defects and abnormal ventricular formation.
Description
Cardiac chamber ballooning (GO:0003242) is a biological process defined as the morphogenic growth in which the chambers of the heart expand in size, contributing to their shaping. This process is a critical component of heart development, enabling the transition from a simple linear heart tube to a multi-chambered organ capable of efficient blood circulation. Understanding the molecular and cellular mechanisms that drive chamber ballooning is essential for researchers studying congenital heart disease, cardiac morphogenesis, and evolutionary developmental biology. The term encompasses the coordinated expansion of the cardiac chambers, which involves cell proliferation, differentiation, and extracellular matrix remodeling. Recent studies have highlighted the role of specific genes and pathways, such as Myosin Vb and N-cadherin trafficking, in regulating this process. As a result, cardiac chamber ballooning has emerged as a focal point for investigations into the genetic and cellular basis of heart formation and disease.
cardiac chamber ballooning At A Glance
| GO ID | GO:0003242 |
|---|---|
| GO term | cardiac chamber ballooning |
| Ontology | biological_process |
| Synonym | none |
| Major function | Morphogenic growth and expansion of heart chambers |
| Definition | The morphogenic growth in which the chambers of the heart expand in size, contributing to their shaping. |
| Related process | Cardiac morphogenesis, heart looping, ventricular formation |
| Key regulator | MYO5B, N-cadherin, Hapln1a |
| Disease relevance | Congenital heart defects, abnormal ventricular development |
What Is GO:0003242?
Cardiac chamber ballooning is the morphogenic growth process in which the chambers of the heart expand in size, contributing to their shaping. This definition, based on the Gene Ontology (GO) term GO:0003242, captures the dynamic expansion of cardiac chambers during development, which is essential for the formation of a functional heart.
Why Is cardiac chamber ballooning Important in Cell Biology?
Cardiac chamber ballooning is fundamental to the formation of a functional heart, as it drives the expansion of cardiac chambers that are necessary for efficient blood pumping. Defects in this process can lead to congenital heart malformations, underscoring its clinical relevance. Moreover, understanding the evolutionary origins of cardiac chambers provides insights into the diversification of vertebrate circulatory systems.
• Critical for the transition from linear heart tube to multi-chambered heart.
• Required for proper ventricular formation and function.
• Involves coordinated cell proliferation, differentiation, and ECM remodeling.
• Disruption leads to congenital heart defects.
• Evolutionarily conserved mechanism for chamber formation.
• Regulated by vesicle trafficking and cell adhesion molecules.
• Influenced by regionalized ECM expansion.
• Studied using zebrafish and mouse models.
• Provides insights into heart regeneration and repair.
• Target for understanding cardiac developmental disorders.
What Happens During cardiac chamber ballooning?
Initiation of chamber expansion
In simple terms: The heart chambers start to grow outward.
Cardiac chamber ballooning begins with the initiation of chamber expansion, a process that involves the coordinated proliferation and differentiation of cardiac progenitor cells. This step is marked by the regionalized growth of the heart tube, which sets the stage for chamber formation.
Cell proliferation and differentiation
In simple terms: Heart cells multiply and specialize to build the chambers.
During chamber ballooning, cardiac cells undergo rapid proliferation and differentiation, leading to the expansion of the chamber walls. This process is regulated by signaling pathways that control cell cycle progression and lineage specification.
Extracellular matrix remodeling
In simple terms: The scaffold around heart cells changes to allow expansion.
Extracellular matrix (ECM) remodeling is essential for chamber ballooning, as it provides structural support and signaling cues for expanding chambers. Hapln1a, a component of the ECM, drives regionalized ECM expansion and promotes heart morphogenesis in zebrafish.
Vesicle trafficking and cell adhesion
In simple terms: Transport inside cells helps stick cells together for chamber growth.
Myosin Vb (MYO5B) is required for correct trafficking of N-cadherin, a cell adhesion molecule, to the cell membrane during cardiac chamber ballooning. Disruption of this trafficking impairs chamber expansion, highlighting the importance of intracellular transport in this process.
Chamber shaping and maturation
In simple terms: The chambers take on their final shape and function.
The final stages of chamber ballooning involve shaping and maturation of the chambers, which includes the formation of trabeculae and the establishment of distinct chamber identities. This step is crucial for the heart to function as a multi-chambered pump.
Key Genes Involved in GO:0003242 cardiac chamber ballooning
The following genes and proteins have been implicated in cardiac chamber ballooning based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYO5B | Vesicle trafficking of N-cadherin | Required for chamber ballooning; knockout impairs expansion |
| CDH2 | Cell adhesion molecule | Trafficking target of MYO5B; mediates chamber morphogenesis |
| HAPLN1 | Extracellular matrix component | Promotes ECM expansion and heart morphogenesis |
| NKX2-5 | Cardiac transcription factor | Regulates chamber identity and ballooning |
| TBX5 | Transcription factor | Involved in chamber specification |
| GATA4 | Transcription factor | Regulates cardiac gene expression during ballooning |
| MEF2C | Transcription factor | Controls chamber growth and differentiation |
| HAND1 | Transcription factor | Essential for ventricular chamber formation |
| HAND2 | Transcription factor | Involved in chamber morphogenesis |
| TBX20 | Transcription factor | Regulates chamber ballooning and maturation |
| NOTCH1 | Signaling receptor | Controls chamber proliferation and differentiation |
| WNT | Signaling pathway | Regulates cardiac progenitor expansion |
| BMP | Signaling pathway | Promotes chamber formation and ECM remodeling |
| FGF | Signaling pathway | Involved in chamber growth and patterning |
| VEGFA | Growth factor | Promotes vascularization during chamber expansion |
| ACTC1 | Cardiac actin | Structural component of expanding chambers |
| MYH7 | Myosin heavy chain | Contractile protein in chamber myocardium |
| TNNT2 | Troponin T | Regulates contractility during chamber ballooning |
How Is cardiac chamber ballooning Regulated?
Cardiac chamber ballooning is regulated by a complex interplay of transcription factors, signaling pathways, and extracellular matrix components. Key regulators include NKX2-5, TBX5, and GATA4, which control chamber-specific gene expression. Signaling pathways such as Notch, Wnt, and BMP modulate progenitor proliferation and differentiation during ballooning. Additionally, vesicle trafficking proteins like MYO5B ensure proper localization of adhesion molecules, which is critical for chamber expansion.
cardiac chamber ballooning and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYO5B | Congenital heart defects | Zebrafish knockout |
| NKX2-5 | Congenital heart disease | Mouse knock-in |
| TBX5 | Holt-Oram syndrome | Human iPSC-derived cardiomyocytes |
| HAPLN1 | Cardiac ECM remodeling defects | Zebrafish overexpression |
| HAND1 | Ventricular hypoplasia | Mouse knockout |
Congenital heart defects
Disruption of cardiac chamber ballooning can lead to congenital heart defects, including ventricular septal defects and hypoplastic chambers. Mutations in genes such as NKX2-5 and TBX5 are associated with human congenital heart disease.
Cardiomyopathies
Abnormal chamber ballooning may contribute to cardiomyopathies characterized by chamber dilation or hypertrophy. Defects in ECM remodeling, as seen with Hapln1a mutations, can impair heart morphogenesis and function.
Evolutionary implications
The evolutionary origin of cardiac chambers is linked to the emergence of chamber ballooning mechanisms, which allowed for the development of high-pressure systemic circulation. Studying this process provides insights into the diversification of vertebrate hearts.
From cardiac chamber ballooning-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MYO5B loss impair chamber ballooning? | Zebrafish MYO5B knockout |
| How does N-cadherin trafficking affect chamber expansion? | Mouse conditional knockout of Cdh2 |
| What is the role of Hapln1a in ECM expansion? | Zebrafish Hapln1a overexpression |
| Can NKX2-5 mutations cause chamber defects? | Mouse NKX2-5 knock-in |
| How does TBX5 regulate chamber identity? | Human iPSC TBX5 knockout |
| Does HAND1 dosage affect ventricular ballooning? | Mouse HAND1 overexpression |
How to Study the cardiac chamber ballooning Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live imaging | Chamber expansion dynamics | Zebrafish heart development |
| RNA-seq | Gene expression changes | Mouse embryonic hearts |
| Single-cell RNA-seq | Cell heterogeneity | Cardiac progenitor populations |
| Proteomics | Protein interactions | MYO5B trafficking complex |
| CRISPR knockout | Gene function loss | Zebrafish MYO5B |
| Knock-in | Mutant protein effects | Mouse NKX2-5 |
| Overexpression | Gain-of-function | Zebrafish Hapln1a |
| In situ hybridization | Spatial gene expression | Chamber-specific markers |
Imaging chamber ballooning
Live imaging using fluorescent reporters in zebrafish and mouse embryos allows visualization of chamber expansion in real time. Confocal microscopy and light-sheet microscopy are commonly used to track morphological changes.
Transcriptomics and single-cell RNA-seq
RNA sequencing of developing hearts can identify genes and pathways active during chamber ballooning. Single-cell RNA-seq reveals heterogeneity among cardiac cell populations.
Proteomics and interactomics
Proteomic approaches can uncover protein-protein interactions, such as MYO5B and N-cadherin, that are critical for chamber ballooning. Mass spectrometry-based interactomics helps define the molecular machinery.
Genetic manipulation in model organisms
CRISPR/Cas9-mediated knockout, knock-in, and overexpression in zebrafish and mice are used to test gene function in chamber ballooning. Conditional alleles allow temporal control of gene disruption.
How CRISPR Can Be Used to Study GO:0003242 cardiac chamber ballooning
Knockout
CRISPR knockout of genes such as MYO5B in zebrafish has demonstrated its essential role in cardiac chamber ballooning, with loss-of-function leading to impaired chamber expansion. Knockout models help identify genes required for chamber morphogenesis.
Point Mutation
Introducing point mutations in genes like NKX2-5 can mimic human congenital heart disease variants and reveal their impact on chamber ballooning. Point mutations in TBX5 have been linked to Holt-Oram syndrome.
Knock-in
Knock-in of fluorescent tags or human disease alleles into endogenous loci allows tracking of protein localization and function during chamber ballooning. For example, tagging N-cadherin with GFP enables live imaging of trafficking.
Overexpression
Overexpression of Hapln1a in zebrafish promotes ECM expansion and enhances heart morphogenesis, demonstrating gain-of-function effects on chamber ballooning. Overexpression models are useful for studying sufficiency of a gene in driving chamber expansion.
How EDITGENE Supports cardiac chamber ballooning Research
Researchers studying cardiac chamber ballooning-related genes often need to determine whether a candidate gene is causally involved in chamber morphogenesis or simply correlated with the process. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for cardiac chamber ballooning research.
Frequently Asked Questions About cardiac chamber ballooning
What is cardiac chamber ballooning?
Cardiac chamber ballooning is the morphogenic growth process in which the chambers of the heart expand in size, contributing to their shaping.
What genes are involved in cardiac chamber ballooning?
Key genes include MYO5B, CDH2, HAPLN1, NKX2-5, TBX5, and GATA4, among others.
What is the GO ID for cardiac chamber ballooning?
The GO ID is GO:0003242.
Why is cardiac chamber ballooning important?
It is essential for the formation of a multi-chambered heart and for efficient blood circulation.
What diseases are associated with defects in cardiac chamber ballooning?
Congenital heart defects, cardiomyopathies, and ventricular hypoplasia.
How is cardiac chamber ballooning studied?
Using live imaging, RNA-seq, proteomics, and CRISPR-based genetic models in zebrafish and mice.
What is the role of MYO5B in chamber ballooning?
MYO5B is required for correct trafficking of N-cadherin, which is necessary for chamber expansion.
How does Hapln1a affect heart morphogenesis?
Hapln1a drives regionalized ECM expansion and promotes heart morphogenesis in zebrafish.
Can CRISPR be used to study cardiac chamber ballooning?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to study gene function in chamber ballooning.
What model organisms are used for cardiac chamber ballooning research?
Zebrafish and mouse are the most common models, along with human iPSC-derived cardiomyocytes.
Conclusion
Cardiac chamber ballooning (GO:0003242) is a fundamental morphogenic process that drives the expansion and shaping of heart chambers during development. Its regulation involves a complex network of genes, signaling pathways, and extracellular matrix components, with critical roles for MYO5B, N-cadherin, and Hapln1a. Disruption of this process leads to congenital heart defects, highlighting its clinical importance. Continued research using advanced CRISPR models and imaging techniques will further elucidate the mechanisms of chamber ballooning and inform therapeutic strategies for heart disease.
References
- 1. Grassini DR et al.. 2019. Myosin Vb is required for correct trafficking of N-cadherin and cardiac chamber ballooning.. Dev Dyn 248(4):284-295 PMID: 30801852
- 2. Kelly RG et al.. 2014. Heart fields and cardiac morphogenesis.. Cold Spring Harb Perspect Med 4(10) PMID: 25274757
- 3. Jensen B et al.. 2020. An Appreciation of Anatomy in the Molecular World.. J Cardiovasc Dev Dis 7(4) PMID: 33076272
- 4. Ebrahimi N et al.. 2022. An integrative multiscale view of early cardiac looping.. WIREs Mech Dis 14(1):e1535 PMID: 35023324
- 5. Simões-Costa MS et al.. 2005. The evolutionary origin of cardiac chambers.. Dev Biol 277(1):1-15 PMID: 15572135
- 6. Risebro CA et al.. 2006. Formation of the ventricles.. ScientificWorldJournal 6:1862-80 PMID: 17205193
- 7. Derrick CJ et al.. 2022. Asymmetric Hapln1a drives regionalized cardiac ECM expansion and promotes heart morphogenesis in zebrafish development.. Cardiovasc Res 118(1):226-240 PMID: 33616638
